UCMSCs as Front-line Approach of Treatment for Patients With aGVHD
Clinical trial NCT03847844 · COMPLETED
Trial details
- NCT number
- NCT03847844
- Sponsor
- Cytopeutics Sdn. Bhd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2023-07-18
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.